1
A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis
Condition(s):Chronic PancreatitisLast Updated:August 22, 2023Recruiting
Paricalcitol: 123 Clinical Trials, Page 1 of 13
Hide Studies Not Open or Pending
2
The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate
Condition(s):Chronic Kidney DiseaseLast Updated:May 21, 2013Completed
3
Intravenous Paricalcitol in Chronic Hemodialysis Patients
Condition(s):Endstage Renal Disease; Secondary HyperparathyroidismLast Updated:January 18, 2017Unknown status
4
Effect of Paricalcitol Over Vessel Wall
Condition(s):NephropathyLast Updated:February 26, 2015Terminated
5
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
Condition(s):Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism (SHPT)Last Updated:August 30, 2023Recruiting
6
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Condition(s):End-Stage Renal Disease; Secondary HyperparathyroidismLast Updated:July 2, 2018Completed
7
Paricalcitol Effect on Anemia in CKD
Condition(s):Anemia; Chronic Kidney DiseaseLast Updated:July 30, 2014Completed
8
The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
Condition(s):Chronic Kidney Disease (CKD) Stage 5; Hypertrophy, Left VentricularLast Updated:January 20, 2012Terminated
9
Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)
Condition(s):Chronic Kidney Disease Stage 3 and 4Last Updated:July 2, 2018Completed
10
Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions
Condition(s):HealthyLast Updated:December 23, 2014Completed